Crosstalk between NF-κB/p65 and β-catenin/TCF4/p300 signalling pathways through alterations in GSK-3β expression during trans-differentiation of endometrial carcinoma cells

Journal of Pathology

Volumn 213, Issue 1, 2007, Pages 35-45

  Saegusa, M ^a   Hashimura, M ^a   Kuwata, T ^b   Hamano, M ^a   Okayasu, I ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

catenin; Endometrial carcinoma; GSK 3 ; Morule; NF B; Trans differentiation

Indexed keywords

BETA CATENIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P300; SYNAPTOTAGMIN I; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR SNAIL; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VIMENTIN; CADHERIN; ESTROGEN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PROGESTERONE RECEPTOR; SNAIL FAMILY TRANSCRIPTION FACTORS; T CELL FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; MESENCHYME CELL; MORULA; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CASE CONTROL STUDY; CELL TRANSDIFFERENTIATION; ENDOMETRIUM; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; METABOLISM; METHODOLOGY; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BETA CATENIN; CADHERINS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL NUCLEUS; CELL TRANSDIFFERENTIATION; CYTOPLASM; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; VIMENTIN;

EID: 34548425241     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2198     Document Type: Article

References (43)

1. -/- colon carcinoma. Science 1997;275:1784-1787.
2. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275:1787-1790.
3. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997;275:1790-1792.
4. Silverman N, Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001;15:2321-2342.
5. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002;109:S81-S96.
6. Li Q, Verma IM. NF-κB regulation in the immune system. Nature Rev Immunol 2002;2:725-734.
7. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, et al.NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004;114:569-581.
8. Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R, et al. The significance of squamous differentiation in endometrial carcinoma: data from a Gynecologic Oncology Group Study. Cancer 1991;68:2293-2302.
9. Buckey CH. Normal endometrium and non-proliferative conditions of the endometrium. In Haines and Taylor Obstetrical and Gynaecological Pathology (5th edn), Fox H, Wells M (eds). Churchill Livingstone: London, 2003; 391-441.
10. Brachtel EF, Sanchez-Estevez C, Moreno-Bueno G, Prat J, Palacios J, Oliva E. Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules). Am J Surg Pathol 2005;29:1322-1329.
11. Saegusa M, Okayasu I. Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 2001; 194:59-67.
12. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. β-Catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 2004; 164:1739-1749.
13. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. Upregulation of TCF4 expression as a transcriptional target of β-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells. Lab Invest 2005;85:768-779.
14. Lamberti C, Lin K-M, Yamamoto Y, Verma U, Verma IM, Byers S, et al. Regulation of β-catenin function by the IκB, kinases. J Biol Chem 2001;276:42276-42286.
15. Cho M, Gwak J, Park S, Won J, Kim D-E, Yea SS, et al. Diclofenac attenuates WNT/β-catenin signaling in colon cancer cells by activation of NF-κB. FEBS Lett 2005;579:4213-4218.
16. Jun S, Hobert ME, Duan Y, Rao AS, He T-C, Chang EB, et al. Crosstalk between NF-κB and β-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2005;289:G129-G137.
17. Kuramoto H, Hamano M, Imai M, Fujisawa T, Kamata Y, Arai T, et al. Hec-1 cells: establishment of an in vitro experimental system in endometrial carcinoma. In Cell and Molecular Biology of Endometrial Carcinoma, Kuramoto H, Nishida. M (eds). Springer-Verlag: Tokyo, 2003; 3-34.
18. Nishida M. Ishikawa cells: opening of in vitro hormone research on endometrial carcinoma. In Cell and Molecular Biology of Endometrial Carcinoma, Kuramoto H, Nishida M (eds). Springer-Verlag: Tokyo, 2003; 35-60.
19. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Battle E, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUCI repression and ZEB1 expression. J Biol Chem 2002;277:39209-39216.
20. Saegusa M, Hashimura M, Okayasu I. CD44 expression in normal, hyperplastic, and malignant endometrium. J Pathol 1998; 184:297-306.
21. Saegusa M, Okayasu I. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas. J Pathol 1997;182:429-436.
22. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nature Cell Biol 2004; 6:931-940.
23. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD. Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 2005;65:2076-2081.
24. Hoeflich KP, Luo J, Rubie EA, Tsao M-S, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 2000;406:86-90.
25. Grotegut S, von Schweinitz D, Christofori G, Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006;25:3534-3545.
26. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev 2000;14:1553-1577.
27. Davies S, Dai D, Feldman I, Pickett G, Leslie KK. Identification of a novel mechanism of NF-κB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2. Gynecol Oncol 2004; 94:463-470.
28. Laird SM, Tuckerman EM, Cork BA, Li TC. Expression of nuclear factor κB in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production. Mol Hum Reprod 2000; 6:34-40.
29. Philippeaux M-M, Piguet PF. Expression of tumor necrosis factor-α and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 1993;143:480-486.
30. Tabibzadeh S, Satyaswaroop PG, von Wolff M, Strowitzki T. Regulation on TNF-alpha mRNA expression in endometrial cells by TNF-alpha and by oestrogen withdrawal. Mol Hum Reprod 1999;5:1141-1149.
31. von Wolff M, Classen-Linke I, Heid D, Krusche CA, Beier-Hellwig K, Karl C, et al. Tumor necrosis factor-α (TNF-α) in human endometrium and uterine secretion: an evaluation by immunohistochemistry, ELISA and semiquantitative RT-PCR. Mol Hum Reprod 1999;5:146-152.
32. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004;118:277-279.
33. Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, et al. Inhibition of integrin linked kinase (ILK) suppresses β-catenin-Lef-1/Tcf-dependent transcription and expression of the E-cadherin repressor, Snail, in APC -/- human colon carcinoma cells. Oncogene 2001;20:133-140.
34. Saegusa M, Hashimura M, Yoshida T, Okayasu I. β-Catenin mutations and aberrant nuclear expression during endometrial tumor genesis. Br J Cancer 2001;84:209-217.
35. Brabletz T, Jumg A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor enviroment. Proc Natl Acad Sci USA 2001;98:10356-10361.
36. Deng J, Miller SA, Wang H-Y, Ixia W, Went Y, Shout BP, et al. β-Catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell 2002;2:323-334.
37. Masui O, Ueda Y, Tsumura A, Konanagi M, Hijikata M, Shimotohno K. RelA suppresses the Wnt/beta-catenin pathway without exerting trans-acting transcriptional ability. Int J Mol Med 2002; 9 :489-493.
38. Vasudevan KM, Gurumurthy S, Rangnekar VM. Suppression of PTEN expression by NF-κB prevents apoptosis. Mol Cell Biol 2004; 24:1007-1021.
39. Bournat JC, Brown AM, Soler AP. Wnt-1 dependent activation of the survival factor NF-κB in PC12 cells. J Neurosci Res 2000; 61:21-23.
40. Schwabe RF, Brenner DA. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-κB activation and apoptosis in hepatocytes. Am J Physiol Gastrointest Liver Physiol 2002;283:G204-G211.
41. Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K, et al. Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity. J Biol Chem 2004; 279:49571-49574.
42. Lau K-F, Miller CCJ, Anderton BH, Shaw P-C. Molecular cloning and characterization of the human glycogen synthase kinase-3β promoter. Genomics 1999;60:121-128.
43. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003;116:1175-1186.